Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1650730

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1650730

Neuromodulation

PUBLISHED:
PAGES: 298 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Neuromodulation Market to Reach US$12.3 Billion by 2030

The global market for Neuromodulation estimated at US$7.2 Billion in the year 2024, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Deep Brain Stimulation segment is estimated at 9.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 10.9% CAGR

The Neuromodulation market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$898.5 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 9.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Global Neuromodulation Market - Key Trends & Drivers Summarized

Neuromodulation is a cutting-edge field within medical science that focuses on altering nerve activity through targeted delivery of electrical or pharmaceutical agents directly to a specific area of the body. This technique is employed in a variety of therapeutic contexts, addressing chronic pain, neurological disorders, and psychiatric conditions by modifying the activity within the nervous system. Neuromodulation encompasses several methods, including spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation, each tailored to treat specific ailments such as Parkinson's disease, epilepsy, depression, and chronic pain syndromes. By precisely controlling neural activity, these therapies offer significant benefits over traditional treatments, often resulting in improved patient outcomes with fewer side effects.

The technology behind neuromodulation has rapidly evolved over the past few decades. Early iterations of neuromodulation devices were bulky and limited in their capabilities. However, advancements in biomedical engineering have led to the development of more compact, sophisticated, and efficient devices. Modern neuromodulation systems often include features such as wireless connectivity, rechargeable batteries, and advanced programming capabilities, allowing for personalized treatment regimens that can be adjusted based on real-time feedback from the patient. Additionally, the integration of machine learning and artificial intelligence is enhancing the precision and effectiveness of these therapies, paving the way for more adaptive and responsive treatment options. Clinical trials and ongoing research are continually expanding the potential applications of neuromodulation, demonstrating its efficacy in treating an ever-growing list of conditions.

The growth in the neuromodulation market is driven by several factors. Firstly, the increasing prevalence of chronic and debilitating conditions such as chronic pain, depression, and neurological disorders has heightened the demand for more effective treatment options. Furthermore, increasing aging population globally, and growing awareness of the efficacy and safety of neurostimulator devices are aiding the market. Secondly, technological advancements have significantly improved the efficacy, safety, and patient acceptance of neuromodulation therapies. Innovations such as minimally invasive surgical techniques and the development of smaller, more durable devices have made these treatments more accessible and appealing to a broader patient population. Thirdly, the growing body of clinical evidence supporting the effectiveness of neuromodulation in improving patient outcomes is fostering greater acceptance among healthcare providers and insurers, further propelling market growth. Lastly, an aging global population is contributing to an increased incidence of neurological and chronic pain conditions, thus expanding the potential patient base for neuromodulation therapies. These factors, combined with continuous research and development efforts, underscore the robust and dynamic nature of the neuromodulation market.

SCOPE OF STUDY:

The report analyzes the Neuromodulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Other Technologies); Application (Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 83 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • Bioness Inc.
  • Beijing Pins Medical Co., Ltd.
  • Axonics Modulation Technologies, Inc.
  • Biegler GmbH
  • Cirtec Medical Corporation
  • Cala Health
  • BioControl Medical Ltd.
  • Atlantic Therapeutics Group Limited
  • Bio-Medical Research Limited
  • Capitol Pain Institute
  • Autonomix Medical
  • Bioinduction
Show more
Product Code: MCP13576

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Neuromodulation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Neurological Disorders
    • A Prelude to Neuromodulation
    • Indications for Neuromodulation Therapy
  • GLOBAL MARKET OVERVIEW
    • Neuromodulation Market Set for a Robust Growth
    • Neuromodulation Market by Segment
    • Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS) Represents the Largest Segments
    • Neuromodulation Devices by Technology
    • Neuromodulation Market by Application
    • Growing Clinical Applications to Drive Demand
    • US and Europe Dominate the Market
    • Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
    • Competition
    • Select FDA Approved Neuromodulation Devices in Recent Years
    • Recent Market Activity
    • Market Restraints and Challenges
  • WORLD BRANDS
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Incidence of Neurological Disorders: A Key Market Driver
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • Recent Developments in Spinal Cord Injury Treatment
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
    • Neuromodulation Technologies to Gain Preference Over Opioids
    • Tibial Neuromodulation to Impact Overactive Bladder Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Transcutaneous Electrical Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Repetitive Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 43: World Neuromodulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of World 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of World Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of World 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!